You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Delamanid

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,

Recruiting
  • Pulmonary TB
  • Delamanid + Bedaquiline + OPC-167832 10 mg
  • +3 more
  • Tembisa, Gauteng, South Africa
  • +7 more
Jun 30, 2022

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • Delamanid
  • +4 more
  • Dasmariñas, Philippines
  • +1 more
Jun 21, 2022

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

Active, not recruiting
  • Infections and Infestations
  • Pulmonary Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +4 more
Sep 13, 2022

Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)

Completed
Has Results
  • Tuberculosis
  • HIV Infections
  • Lima, Peru
  • +2 more
Jan 20, 2022

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Expand New Drugs for TB [endTB]

Completed
  • Tuberculosis, Multidrug-Resistant
  • This is a non-intervention observational study
  • Abovyan, Armenia
  • +15 more
Jun 9, 2022

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))

Terminated
Has Results
  • Tuberculosis
  • Delamanid
  • Optimized Background Regimen (OBR)
  • Ogre, Latvia
  • +2 more
Oct 14, 2021

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +16 more
Dec 13, 2022

Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

Completed
Has Results
  • Tuberculosis, Multidrug-Resistant
  • Beijing, China
  • +7 more
Sep 30, 2021

Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Tbilisi, Georgia
  • +11 more
Feb 14, 2022

Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))

Recruiting
  • Tuberculosis, MDR
  • Delamanid (DLM)
  • +2 more
  • Gaborone, South-East District, Botswana
  • +26 more
Sep 22, 2022

Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +5 more
  • Bedaquiline 100 MG
  • +4 more
  • Pune, India
  • +9 more
Mar 2, 2022

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

Completed
Has Results
  • Tuberculosis, Pulmonary
  • +2 more
  • Delamanid
  • +2 more
  • San Antonio, Texas
  • +16 more
Nov 1, 2021

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

    Recruiting
    • MDR-TB
    • PRS Regimen V
    • MDR-TB Treatment Regimen(WHO)
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 4, 2022

    Multidrug-resistant Tuberculosis Trial in Worldwide (Delamanid + OBR, Placebo + OBR)

    Completed
    Has Results
    • Multidrug-resistant Tuberculosis
    • Delamanid + OBR
    • Placebo + OBR
    • Tartu, Estonia
    • +16 more
    May 13, 2019

    Antiretroviral Drugs and Related Drugs During and After

    Completed
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +61 more
    Jun 28, 2022